Publicaciones en las que colabora con MYRIAM JESÚS BARANDIARAN AMILLANO (41)

2024

  1. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

  2. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  3. GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe

    Alzheimer's Research and Therapy, Vol. 16, Núm. 1

  4. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

2023

  1. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

    Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700

  2. Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries

    JAMA Neurology, Vol. 80, Núm. 3, pp. 279-286

  3. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

    Journal of Neurology, Vol. 270, Núm. 4, pp. 1976-1988

  4. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1573-1586

  5. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1466-1477

  6. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

    Brain, Vol. 146, Núm. 1, pp. 321-336

  7. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

    Alzheimer's and Dementia, Vol. 19, Núm. 5, pp. 1947-1962

2022

  1. CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 11, pp. 1764-1777

  2. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  3. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia

    Alzheimer's and Dementia, Vol. 18, Núm. 7, pp. 1408-1423

  4. Data-driven staging of genetic frontotemporal dementia using multi-modal MRI

    Human Brain Mapping, Vol. 43, Núm. 6, pp. 1821-1835

  5. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  6. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

    Cortex, Vol. 150, pp. 12-28

  7. Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72

    Brain Communications, Vol. 4, Núm. 4

  8. Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study

    Annals of Neurology, Vol. 91, Núm. 1, pp. 33-47

  9. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

    Neurobiology of Aging, Vol. 114, pp. 94-104